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Private Enterprise for Public Health
Opportunities for Business to Improve 
Women’s and Children’s Health
A Short Guide for Companies
What is Every Woman Every Child? 
The Every Woman Every Child effort was launched by the United Nations Secretary-General, Ban Ki-moon, during the United Nations 
Millennium Development Goals Summit in September 2010. It is an unprecedented global movement that aims to save the lives of 
16 million women and children in the 49 poorest countries by 2015 and accelerate achievement of the Millennium Development Goals. 
It works to mobilize and intensify international and national action by governments, multilaterals, the private sector and civil society 
to address the major health challenges facing women and children around the world. The initiative puts into action the Global Strategy 
for Women’s and Children’s Health. This presents a roadmap on how to enhance financing, strengthen policy and improve delivery of 
the health services and products needed in the countries to help women and children. 
For more information on the Every Woman Every Child effort, please visit www.everywomaneverychild.org. 
A Guide for Companies 
This document highlights a broad range of specific and practical opportunities for improving the health of women and children while 
also generating value for private enterprise. We call this “shared value”. It provides information about the health needs of women 
and children in developing and emerging economies to help companies identify where they can have the greatest impact. Private 
Enterprise for Public Health aspires to catalyse a collective approach to creating transformative partnerships to help to save the lives 
of 16 million women and children. These partnerships need to be sustainable and scalable and include a broad range of stakeholders 
to make lasting progress. 
While this document provides practical opportunities for private enterprises to engage in improving women’s and children’s health, 
we expect the business community to behave responsibly and to respect human rights in general (and women’s and children’s rights 
in particular). We also expect private enterprises to uphold the principles of preventing harm and actively safeguarding women’s and 
children’s interests within their own operations in the marketplace and the community (a list of relevant principles is listed in the 
references section). 
This guide originated in collaboration with the Innovation Working Group (IWG) in support of Every Woman Every Child. The 
Partnership for Maternal, Newborn & Child Health (PMNCH), which hosts the secretariat of IWG, developed this guide with social 
impact consultants FSG, in collaboration with the World Health Organization (WHO) and the United Nations Foundation (UNF), 
supported by the Norwegian Agency for Development Cooperation (Norad). 
Disclaimer 
The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by 
the Partnership for Maternal, Newborn & Child Health or the World Health Organization in preference to others of a similar nature 
that are not mentioned. 
All reasonable precautions have been taken by the authors to verify the information contained in this publication. However, the published 
material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and 
use of the material lies with the reader. 
This publication contains collective views based on an extensive consultation process and does not necessarily represent the opinions 
or the policies of the Partnership for Maternal, Newborn & Child Health, or its hosting agency, the World Health Organization.
The Secretariat of the Partnership for Maternal, Newborn & Child Health is hosted and administered by the World Health Organization.
Publication reference: Private Enterprise for Public Health. Opportunities for Business to Improve Women’s and Children’s Health. 
A Short Guide for Companies. Geneva, Switzerland: PMNCH.
© The Partnership for Maternal, Newborn & Child Health. World Health Organization (WHO), 2012. All Rights Reserved.
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Women’s and children’s health is a unique area where compassion, altruism and economics combine in a 
single cause. By saving lives, we not only do something morally right but also help build more prosperous, 
productive communities. 
The inextricable link between a country’s health and its wealth is widely understood. Women and children 
represent more than half of the world’s population, so their well-being is a cornerstone of human 
development and progress. Women who are health literate and can access the health care they need to  
give birth safely – and ensure their babies get a healthy start in life – create the preconditions for economic 
growth and prosperity. 
However, countries working alone, or with development partners, cannot do everything required to raise 
standards of health. They urgently need the support of private enterprise, with its global scale, energy and 
influence. In this report, we urge businesses to apply all their skills to tackle the problem of women’s and 
children’s health with innovative solutions, novel transformational business models and new mindsets – as 
well as established methods that are already known to work. In this way, companies can make a unique 
contribution. And, by creating “shared value” – a key concept here – they benefit their own balance sheets 
and reputations while addressing social issues. 
The business case is clear: per capita health expenditure by public and private sources has grown by almost 
14% in over 70 developing countries, while private finance, including private capital investment, now comprises 
82% of the developed world’s total economic engagement with developing countries. There are several global 
initiatives recognizing these new dynamics, including the United Nations Secretary-General’s work with 
leading global companies to strengthen business partnerships across the United Nations system, work of  
the Innovation Working Group in support of Every Woman Every Child to scale innovations and catalyse 
sustainable public-private partnerships, and the aims of the United Nations Commission on Life-Saving 
Commodities for Women and Children and the Commission on Broadband for Digital Development. 
This document entitled Private Enterprise for Public Health dovetails with these efforts. It is a practical 
“what, where and how” guide intended to inspire new and existing private sector players to make a massive 
difference by doing what they do best – innovate, and apply their core capabilities, technologies and processes, 
in partnership with others, to solve complex and interrelated problems in women’s and children’s health. 
Now, the next step is to focus our collective action on developing solutions and bringing them to scale in 
countries where needs and opportunities exist. 
Foreword “ Every Woman Every Child. 
This focus is long overdue. 
With the launch of the Global Strategy 
for Women’s and Children’s Health, 
we have an opportunity to improve 
the health of hundreds of millions of 
women and children around the world, 
and in so doing, to improve 
the lives of all people. ”
— United Nations Secretary-General 
Ban Ki-moon
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Tore Godal, Special Advisor to the Prime Minister of Norway on Global Health, 
 and Scott Ratzan, Senior Vice President, Global Health, Johnson & Johnson. 
Co-chairs of the United Nations Secretary-General’s Innovation Working Group for Every Woman Every Child.
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Companies can help save 16 million lives by 2015
 – Women’s and children’s health is an urgent global challenge: 7.6 million children under the age of five and 
287 000 mothers die every year. The world needs to do more if we are to meet the health-related Millennium 
Development Goals.
 – The private sector has a unique ability to innovate to create financially self-sustaining solutions to challenges 
in women’s and children’s health. Active engagement by companies, both philanthropically and through 
the core business, is critical to the success of global efforts on this issue. Growing populations and rising 
health spending may create new opportunities for companies to meet these challenges, both through the 
business and through philanthropy and CSR initiatives.
 – Doing so can also benefit companies themselves.
Different industries are well placed to address a range of unmet health needs
 – Different industries can leverage their unique competencies to work on different aspects of the health system.
 – Multiple, interrelated needs must be met if the health of women and children is to improve. 
 – To meet these needs, a functioning health system must be in place. This includes enabling policies, innovative 
products, delivery technologies and trained health workers.
Through partnerships, companies can create “shared value” around these needs
 – Companies can meet these needs in ways that also create short- or long-term value for the business: they can 
create shared value around women’s and children’s health.
 – Companies can create shared value on three distinct levels: by reconceiving products and markets, by 
reconfiguring value chains and by strengthening local clusters.
 – While initiatives rooted in the core business are likely to be the most sustainable and scalable, philanthropy 
and corporate social responsibility also have a role to play in creating shared value, as well as in areas of 
market failure where shared value opportunities cannot be found. They are most effective when they 
leverage companies’ unique assets and expertise.
 – In all cases, cross-sector, cross-industry partnerships are key to success: companies rarely have the legitimacy, 
expertise and resources to act in isolation.
Collective impact offers a blueprint for transformative health partnerships
 – Companies can ensure collective impact and “change the game” by working in a mutually reinforcing way with 
partners from across sectors and complementary industries to transform health systems in a specific location.
 – Such transformative partnerships are not easy or straightforward – initiatives require investment to align 
objectives and expectations, coordinate action and measure progress.
 – However, they have the potential to transform women’s and children’s health and to create new opportunities 
for business.
Next steps: the time to act is now
 – Companies can use this guide as a starting point to identify opportunities to contribute to the Every Woman 
Every Child effort and join the global movement to save 16 million lives by 2015.
 – Companies can then prioritize the opportunities aligned with their core competencies and build the business case.
 – To create shared value through partnerships, companies can leverage various “catalysts” to develop and scale 
their initiatives in countries by joining partners in the Innovation Working Group; The Partnership for Maternal, 
Newborn & Child Health and working with the United Nations Foundation and the UN Global Compact.
 – Companies can share their actions as a commitment to the global Every Woman Every Child effort. For more 
information and upcoming opportunities visit www.everywomaneverychild.org.
Key Messages
“ Each year, about 7.6 million children 
under five die from preventable causes 
and almost 300 000 women die needlessly 
in pregnancy and childbirth, so the scale of the 
problem is immense. We need to do something 
dramatic to save these lives, and that’s where 
the ideas, resources and energy of private 
enterprise will make a crucial difference. ”
— Flavia Bustreo, 
Assistant Director-General, WHO, 
PMNCH Board Member
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1. Why explore opportunities in women’s 
and children’s health?
The private sector has a unique ability to 
innovate, to create self-sustaining solutions  
to challenges in women’s and children’s 
health. Active participation by companies in 
the Global Strategy – both through the core 
business and philanthropically – is critical  
to its success.
Companies can help save 16 million women’s and children’s lives by 2015
The private sector has a unique ability to innovate to create self-sustaining solutions to challenges in women’s and 
children’s health. Active participation by companies in global efforts to make a difference – both philanthropically and 
through the core business – is critical to the success of the Global Strategy for Women’s and Children’s Health (see below).
Women’s and children’s health is an urgent global challenge. 7.6 million children under the age of five and 287 000 mothers 
die every year.1 The tragedy behind these numbers is that an estimated 21 000 children’s deaths and 1000 maternal deaths 
could be prevented every day.2 These deaths have a devastating effect – not only on families but also on society, because 
women’s and children’s health is the basis of social welfare and economic growth, and a prerequisite for the achievement 
of many other development goals.3
If the investments identified as necessary in the Global Strategy for Women’s and Children’s Health were made, they 
would have the following impact by 2015 in the 49 poorest countries alone:4
 – 19 million more women would give birth supported by a skilled birth attendant;
 – 2.2 million additional neonatal infections would be treated;
 – 15.2 million more children under one year of age would be fully immunized; and 
 – 40 million more children would be protected from pneumonia.
Progress towards these goals has been made. However, less than four years remain until the 2015 deadline set in the 
Millennium Development Goals. If we are to meet those goals, the world needs to do more.
To rise to this challenge, the United Nations Secretary-General, 
Ban Ki-moon, launched The Global Strategy for Women’s and 
Children’s Health at the United Nations Millennium Development 
Goals Summit in September 2010. The Every Woman Every Child 
initiative resulted as a means of putting the Global Strategy into 
action. It aims to mobilize and intensify action by governments, 
multilaterals, the private sector and civil society to address the 
major health challenges facing women and children around the 
world. The overall aim is to save the lives of 16 million women 
and children by 2015.
Diverse industries are using their core competencies to address health needs
In developing this guide, over 70 private sector initiatives were reviewed from five key industries (pharmaceuticals; medical 
devices; digital technologies; financial services; and media, communication & entertainment). This review shows that most 
companies focus on their core competencies when contributing to women’s and children’s health:
 – Pharmaceutical and medical device industries focus on health products and services for women and children. 
However, they also invest significantly in delivery infrastructure and systems to enable their businesses to operate 
efficiently in new markets. Examples include Merck, Pfizer, J&J, Novartis, GSK, Aspen Pharmacare, Becton Dickinson, 
GE and several others.
 – Digital technology (IT and telecoms) companies enable health systems by improving communications and the ability 
to process information. This has been demonstrated by the pattern of their investments in recent years by companies 
including Hewlett-Packard, Intel, Vodafone, Orange-France Telecom, Bharti Airtel, Safaricom, Wipro and others.
 – Financial services companies focus on health financing (e.g. health system funding, insurance and payment services). 
Examples include Bajaj Allianz and ICICI Lombard. Working with partners they can raise awareness of the availability 
of health financing, contribute to policy and governance decisions and help generate more demand for their services.
 – Media, communication and entertainment companies’ products and services are used to deliver health messages 
to people, for example through radio, television, social media or text messages. Innovative examples include Globo 
TV, BBC, DMI and others. They can also be used to mobilize resources in innovative ways. 
Several other industries are well placed to address women’s and children’s health needs. Food and beverage companies 
innovate to develop new, more nutritious products and to realign their value chains to deliver them reliably and at low cost. 
8They can also help promote healthy eating. For example, the nutrition company DSM has partnered with the World Food 
Programme to develop and distribute fortified rice that delivers affordable micronutrients to more than 10 million people 
in some of the world’s poorest countries.
Similarly, consumer products companies can address issues of hygiene and sanitation. For example, Hindustan Unilever Ltd. 
launched a major campaign (Swasthya Chetna) to increase handwashing in India. It did this by stepping up distribution 
of its Lifebuoy soap brand, alongside a US$ 5 million education campaign running over five years.
In many countries, there are also opportunities for businesses (large and small) to engage directly in health service delivery. 
They can do this in areas such as patient transportation services, laboratories, clinics and hospitals. Logistics and 
transportation companies like DHL and TNT help both the public and private sectors to maximize supply chain efficiency 
and meet customer needs. 
Rising spending on health in developing countries may open investment 
opportunities for companies
The upward trend of health spending in developing countries points to a long-term opportunity for companies. In these 
countries, the size of health markets, measured both by population and by value, is growing rapidly – faster than GDP. 
In the 74 developing countries that face the greatest challenges in women’s and children’s health:5
 – total population grew from 4.28 billion to 4.84 billion between 2000 and 2009; 
 – there are roughly 500 million children under the age of five and 1.7 billion women above the age of 15 (2010);6
 – total health spend – including public and private sources – increased from 4.8% of GDP in 2000 to 5.5% in 2009;
 – average health expenditure per capita, including both public and private sources, grew at 13.9% per year between 
2005 and 2009 (see Figure 1).7 
Figure 1
Evolution of average per capita health expenditures across 73 developing countries from 2005-09 (USD)
These data suggest that companies that innovate to reach new consumers through their business are likely to see the 
value of developing-country markets grow over time. Greater public and private investment in health systems will also 
increase the chances of philanthropic and CSR initiatives successfully achieving social impact.
The specific needs and opportunities vary by location. Women and children in different places have different health needs. 
For example, in Botswana 96% of HIV positive pregnant women receive antiretroviral (ARV) treatment for the prevention of 
mother-to-child transmission of HIV, whereas in Pakistan only 0.4% of HIV positive pregnant women receive ARVs.8 Similarly, 
different market dynamics mean that an approach that is effective in one country may have little relevance in another. 
For example, most health spending in South Africa is controlled by the public health system, while in India and Nigeria 
more than 70% of spending is out-of-pocket.9 These differences mean that companies need to tailor their market strategies 
to the specific circumstances of women and children in the respective markets. However, this should come naturally to 
most successful international companies, which are used to adapting their products and services to different markets. 
The three examples in Box 2 illustrate the dimensions of some emerging markets, and give an indication of the potential 
market opportunities. Nigeria, Andhra Pradesh (India) and Peru were selected to reflect one market from Africa, Asia 
and Latin America respectively. The data points are indicative of both the overall size of the health sector and specific 
challenges related to women’s and children’s health in the respective markets.
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Nigeria
Population (2009): 154 million 
GDP (2009): US$ 173 billion
Children under 5 (2010): 26.6 million
Women above 15 years of age (2010): 45.4 million
 – In 2009, Nigeria spent US$ 11 billion on health 
care (36% government, 64% private); 96% of 
private health expenditures are out-of-pocket.
 – Total expenditures on health grew at an 
annual rate of 13% between 2005 and 2009.
 – 3.7 million pregnant women do not have 
access to a skilled health worker at birth.
 – 2.3 million infants aged 12-23 months do not 
receive 3 doses of combined diphtheria, 
pertussis and tetanus vaccine.
aNdhra Pradesh, iNdia
Population (2011): 76 million
GDP (2009): US$ 55 billion
Children under 6 (2011): 8.6 million
Women and girls above 6 years of age (2011): 
38.0 million
 – In 2007, the Government of India committed 
to increase government health spending 
from 1% to 2-3% of GDP by 2012; 70% of 
Indian health spending is out-of-pocket.
 –Due to the rollout of a governmental health 
insurance programme in 2007, 85% of Andhra 
Pradesh’s population is now health insured.
 – 23% of all births are not assisted by a skilled 
health worker.
Peru
Population (2009): 29 million
GDP (2009): US$ 130 billion
Children under 5 (2010): 2.9 million
Women above 15 years of age (2010):  
10.4 million
 – In 2009, Peru spent US$ 6.7 billion on 
health care (58% government, 42% 
private; 85% of private health expenditure 
is out-of-pocket).
 – Total expenditure on health grew at an 
annual rate of 15% between 2005 and 2009.
 – 176 000 pregnant women do not have 
access to a skilled health worker at birth.
Figure 3
Creating Shared Value11
Box 2
Select Market - Estimates10
Companies can benefit by pursuing opportunities in these and similar markets
Leading companies are starting to find ways to create shared value (see Figure 3 below) around women’s and children’s 
health. They do so by innovating around products, value chains and clusters (the health systems, infrastructure, supporting 
industries, policies and social norms that surround business operations). And they improve the health of women and children 
by helping them gain access to affordable health care – while also creating short- and long-term value for the business.
In addition to these opportunities to create shared value, investing in women’s and children’s health – and being part of a 
coordinated, global effort – can benefit companies in other ways. For example, it can positively influence how customers 
perceive the brand and increase customer loyalty. It can also motivate employees and make them feel more engaged with 
the company – especially if it offers employees the chance to participate actively in such efforts.
Definition
“The concept of shared value can be defined as policies and operating practices that enhance the competitiveness of a company while 
simultaneously advancing the economic and social conditions in the communities in which it operates” — Porter & Kramer (2011)
Approach
Companies can innovate to create shared value on three levels:
Reconceive  
products and markets
Redefine productivity  
in value chains
Strengthen local 
clusters
Rethink target markets and populations, 
and innovate products and services,  
to meet underserved needs
Reconfigure business operations,  
from R&D to after-sales, in ways  
that increase productivity
Invest in strengthening the “ecosystem”  
of industries, institutions and norms that 
enable the company to operate competitively
1 2 3
Shared Value Creation
Value for Health Value for Companies
 – Improve access to care and treatment
 – Lower cost of meeting health needs
 – Improve health outcomes
 – Increase market value and share
 – Reduce costs and risks
 – Increase customer loyalty
Creating Social Value
Investments that address social  
and environmental objectives
Creating Shared Value
Investments in long-term business 
competitiveness that simultaneously 
address social and environmental 
objectives
Creating Business Value
Investments in long-term  
competitiveness
Shared value is created when both social and business issues are addressed,  
connecting a company’s success with social progress
*Source: FSG and Michael Porter 2012
“ Innovative public-private partnerships 
can help ensure that the right people are 
in the right place, and with the right 
resources and technologies to improve 
women’s and children’s health. ” 
— Carole Presern,  
Director, PMNCH
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2. What needs and opportunities exist?
Women and children have multiple, interrelated health needs 
Drugs and vaccines are important to women’s and children’s health, but by no means represent the entire solution. 
The problem is complex, because the health needs of women and children are interrelated and overlap within a system 
(see Figure 4). Many of these needs have to be addressed simultaneously if we are to make meaningful progress toward 
the health-related Millennium Development Goals.
Figure 4
System of health needs
Consider, for example, the health needs of a woman with complications during her pregnancy. Clearly, she needs access 
to appropriate medical equipment and drugs (Health Products & Services). In all likelihood, she’ll need attention from 
specialist staff in a local clinic – and she may need an ambulance service to get her there (Delivery Systems & Infrastructure). 
Those staff need to be adequately trained and managed (Workforce Development). But the availability of these things 
would be of no use if the pregnant woman had not been made aware of the symptoms and physical signs to look out 
for during pregnancy, and informed of the treatment and entitlements available to her (Awareness & Behaviour). She also 
needs to be able to afford this medical treatment (Financing). Finally, to guarantee the overall existence and quality of 
the intervention, the government needs to enforce proper standards of care (Policy & Governance).
Companies are well placed to address many gaps across this system
At the global level, it is possible to identify a number of areas where companies may be well positioned to fill gaps in the 
provision of health care. These are illustrated in the tables below. The specific gaps and needs vary by country and 
population segment, so companies should thoroughly investigate and understand specific opportunities before investing, 
and should not rely on this document for guidance. Nevertheless, it offers a starting point for such specific analysis.
Health products & services
The table below illustrates some key opportunities for product and service innovation along the “Continuum of Care” 
for reproductive, maternal, newborn and child health (RMNCH). The RMNCH Continuum of Care represents the ideal 
delivery of integrated health services and interventions for mothers and children from pre-pregnancy through to 
delivery, infancy and childhood. A wide range of medical technologies and other products are needed to put together 
comprehensive, integrated packages of essential interventions and to provide integrated care for women and children.
Adolescence & 
Pre-Pregnancy
Pregnancy  
(Antenatal)
Birth Postnatal 
(Mother)
Postnatal  
(Newborn)
Infancy & 
Childhood
P
re
ve
nt
io
n  –Vaccines and Medicines to prevent 
and manage STIs 
(including HIV)
 – Innovative female 
contraceptives  
(e.g. microbicides)
 –New tetanus vaccines  –Prophylactic 
uterotonics
 –New vaccines for  
h. influenza, 
meningococcal, 
pneumococcal  
and rotavirus
 –Needle free vaccines
D
ia
g
n
o
si
s
 –Diagnostics for STIs 
(including HIV)
 –Cervical cancer 
diagnostics
 –Diagnostics for syphilis
 –Affordable mobile, solar 
powered ultrasound
 –Devices to detect and 
monitor maternal  
and fetal heart rates, 
uterine contractions 
and blood pressure
 –Diagnostics 
for serious 
infections 
after birth
 –Early infant 
diagnosis for HIV
 –Point of care 
diagnostics for 
newborn sepsis
 –Devices to measure 
paediatric blood and 
oxygen levels for 
childhood pneumonia
Tr
e
at
m
e
nt
 /
 C
ar
e  –Antiretroviral therapies for prevention of mother 
to child transmission
 – Intermittent preventive 
treatments in pregnancy 
against malaria
 –Corticosteroids for 
preterm deliveries
 – Improved 
formulation 
of 
uterotonics
 –Uterine 
balloons to 
manage 
cases of 
postpartum 
haemorrhage
 –New antibiotics  
for newborns
 –Safe platforms  
for neonatal 
resuscitation 
(suction apparatus 
and self-inflating 
bag-and-mask)
 –Ultraviolet tables 
for jaundice
 – Low cost infant 
warmers / incubators
 –Ventilators for babies
 –Paediatric 
formulations of 
antimalarials
 – Low cost, solar powered, mobile health devices / Point of care diagnostics
 – Nutrition fortification (folic acid, iron, calcium)
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Learn more about what is needed: 
Essential Interventions, Commodities and Guidelines for Reproductive Maternal, Newborn and Child 
Health, PMNCH, 2011
Learn about specific interventions and products that have been proven to reduce reproductive, maternal, 
newborn and child mortality, and promote reproductive health.
www.who.int/pmnch/topics/part_publications/201112_essential_interventions/en/index.html
UN Commission on Life-Saving Commodities for Women and Children, 2012
Learn about 13 essential overlooked commodities that have the potential to save the lives of women  
and children. This report identifies opportunities for increased production, supply, and use of affordable,  
high-quality, high-impact medicines and health supplies that have the potential to improve newborn,  
child, maternal, and reproductive health.
www.everywomaneverychild.org/resources/un-commission-on-life-saving-commodities/life-saving-commodities
Table 5
Continuum of Care: Health Product & Services
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Family & 
Community
Outpatient & 
Outreach Services
Hospitals & 
Health Facilities
Linking Places of  
Care Giving
 – Innovative packaging and 
pricing, and reconfigured value 
chains for household-level 
products  
(e.g. insecticide-treated bed 
nets, contraceptives)
 –Technologies to disseminate 
health information  
(e.g. family planning)
 –Technologies to enable access 
to financial services  
(banking, insurance)
 – Immunization & health 
counselling campaigns
 –Mobile labs and clinics
 –Maternity waiting homes
 –SMS applications for health 
workers-patient communication
 –Systems to monitor doses 
and temperatures of HIV and 
TB drugs
 –Technologies to capture field 
data in electronic repositories
 – Innovative packaging and 
pricing, and reconfigured 
value chains for clinical  
level products (e.g. surgical 
equipment, antibiotics, 
uterotonics)
 –Medical records
 –Medical transportation  
(e.g. ambulances)
 –Tele-medicine
 –Technologies to transfer 
patient data (e.g. test results) 
to health facilities
 – Stock and logistics 
management systems
Delivery systems & infrastructure
The table below depicts some opportunities for companies to build the delivery systems and infrastructure needed to make 
products and services more readily available to women and children at different levels of care giving. Reconfiguring 
value chains and using mobile technologies to reach people who live in remote places are particularly relevant.
Table 6
Continuum of Care: Delivery Systems & Infrastructure
14
Workforce Development Policy & Governance Awareness & Behaviour Financing
 –Training of skilled health 
attendants (midwives, nurses, 
doctors)
 –Training of hospital staff, 
physicians and pharmacists  
to use complex technologies
 –Training of field health 
workers to administer drugs 
and vaccines correctly and 
provide accurate health 
information to patients
 –Data collection technologies to 
inform policy makers (e.g. gaps 
in care provision, epidemiology)
 – IT systems to help decision-
makers generate and analyse 
data
 –Better guidelines and standards 
of care
 –Resource mobilization and 
health advocacy
 –Consistent manufacturing 
standards and trade rules
 –Registration and device approval
 –National behaviour change 
campaigns
 –Customized information to 
improve health education and 
trigger health seeking 
behaviour
 –Campaigns targeting 
specifically health workers
 –General health and hygiene 
education
 – Investment capital for health 
facilities and hospitals  
(e.g. innovative debt-financing 
mechanisms) 
 –Customized financial services 
(microfinance, microinsurance) 
for women
Enabling environment
The table below sets out a range of opportunities for companies to improve the enabling environment for women’s and 
children’s health. In other words, to help create an environment in which more (and more-effective) health care can be 
delivered to women and children when and where they need it. Companies can do this either as a contribution to a 
public or non-profit-sector-led effort, or to improve the context for other business activities. Through their business 
activities, companies can help develop the health workforce, strengthen policy and governance, increase demand for 
products and services by raising public awareness and expand health financing.
Table 7
Continuum of Care: Enabling Environment
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Heath Products  
& Services
Delivery Systems & 
Infrastructure
Enabling  
Environment
Ph
ar
m
ac
e
ut
ic
al
Develop new pharmaceutical products 
or adapt existing ones to meet women’s 
and children’s needs in a new way
E.g. Boehringer-Ingelheim and J&J - Gilead/ 
once daily HIV treatment
E.g. GSK and Crucell-J&J/development of 
new malaria vaccine
E.g. Pfizer and Shanghai Dahua/ injectable 
contraceptives
Extend the reach of pharmaceutical 
products through innovative packaging 
and pricing and / or a reconfigured 
value chain 
E.g. Novartis-Sandoz/ Arogya Parivar
E.g. Gilead Sciences / Licensing of 
antiretroviral manufacturing 
E.g. GSK, Merck, J&J / Tiered pricing
Training health workers to deliver 
products; support for community 
health education; input to standards of 
care / treatment guidelines
E.g. Novartis-Sandoz/ Arogya Parivar
E.g. Merck Vaccine Network
M
e
d
ic
al
 D
ev
ic
es New or adapted devices / diagnostics 
that are appropriate for resource-poor 
settings
E.g. GE / Embrace infant warmer
E.g. Great Connection / Mobile ultrasound 
device
E.g. Siemens / ACUSON P10™ ultrasound
Reconfigured value chains to develop, 
produce, deliver and provide after-sales 
support for products
E.g. Roche / AmpliCare programme
Training for health workers and 
laboratory staff; screening campaigns; 
input to regulatory frameworks; 
guidelines for effective diagnosis
E.g. BD / Laboratory Strengthening 
programme
D
ig
ita
l T
ec
h.
  
(IC
T,
 T
e
le
co
m
s)
Not a core competency
Technologies to enable the 
dissemination of health information, 
access to financial services, capture 
and transfer of patient data, and stock 
management and tracking 
E.g. Bharti Airtel / SMS-based Health Packs
E.g. Safaricom / Changamka Microhealth
E.g. Vodafone – IBM / SMS for Life
E.g. Hewlett-Packard etc. / Drug 
authentication service
Technologies to support training 
of health workers, help decision 
makers generate and analyse data, 
or disseminate public engagement 
information
E.g. Intel / World Ahead Program
E.g. Globe Telecom / i-philhealthy 
campaign
Fi
na
nc
ia
l 
Se
rv
ic
es
Not a core competency Not a core competency
Health insurance/payment services; 
infrastructure investment
E.g. Bajaj Allianz / Health Micro insurance 
product 
E.g. GA Insurance / Changamka Microhealth
E.g. LeapFrog Investment / Shriram CCL
M
ed
ia
, C
o
m
m
un
ic
at
io
n 
 &
 E
nt
e
rt
ai
nm
e
nt
Not a core competency Not a core competency
Behaviour change / health education 
messaging (through adverts, shows); 
Content development & provision; 
Resource mobilization / advocacy
E.g. Globo TV / Heath messaging in 
entertainment programmes
E.g. DMI / Window to Love
E.g. 100 media orgs. / Born HIV Free 
Campaign
Examples of how different industries can leverage core competencies to 
address different health needs
This table provides an overview of five key industries with specific examples of best practices including pharmaceutical, 
medical devices, ICT, financial services and media & communication, and their core competencies in different aspects 
of the health system to improve women’s and children’s health. 
Table 8
Alignment of core competencies of five key industries with different aspects of the health system
“ By helping to address one of the world’s 
oldest and most preventable global health 
tragedies, we believe ‘Merck for Mothers’ 
will have an important impact on society. 
We also believe it will provide valuable 
learnings to our business. We are in this 
fight for the long term. ”
— Kenneth C. Frazier,  
Chairman of the Board,  
President and Chief Executive Officer, Merck
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3. How can companies act?
Companies can act to improve women’s and children’s health in four ways: 1) philanthropic investments and corporate 
social responsibility; 2) workplace policies that actively safeguard women and children; 3) external public policy dialogue; 
and 4) commercial business operations. However, these areas are interrelated, so companies’ activities in them will often 
overlap. In all cases, partnerships are critical for success.
A powerful way for companies to act is to seek to create shared value around women’s and children’s health. For example, 
they could create shared value by pursuing opportunities that lower the cost of health care, expand access or improve 
health outcomes – while at the same time benefit the business by increasing market size or value, improving customer 
loyalty or lowering business risks or costs. Shared value initiatives should and do create economic value over the longer 
term, and make it easier for companies to focus resources and innovation on the problem. As a result, shared value 
initiatives are often more effective, sustainable and scalable in the long term than aid programmes that are not connected 
to business interests. They do not always need to generate short-term returns for companies in order to benefit women 
and children. 
An important caveat is that, when pursuing shared value, companies should at all times respect and promote human 
rights in general, including the rights of women and children. This can be done by actively safeguarding the rights of 
women and children within companies’ operations, in the marketplace and in the community.
Companies invest in core business to create shared value 
Reconceiving products and markets
The most obvious way in which companies can create shared value around women’s and children’s health is through 
product and service innovation. These efforts are most successful when they start from creative thinking about the 
potential market: what women and children in specific market segments need but cannot access; why that is the case; 
and how a company’s products and expertise may be able to bridge the gap.
Once market opportunities have been identified, companies can innovate to address them in several ways:
 – They develop new products and services that meet health needs in new ways. For example, financial service firms 
like Bajaj Allianz and ICICI Lombard in India, or GA Insurance in Kenya (among others), are developing new health 
microinsurance products. These have the potential to transform the ability of poor women to pay for their, and 
their children’s, health care. Similarly, IT companies such as Hewlett-Packard and Sproxil are developing new 
technologies that allow consumers to check the authenticity of drugs at the point of sale.
 – They adapt existing products and services to lower cost, increase safety and better meet the needs of women and 
children. For example, medical device companies such as GE and Medtronic are adapting products for use in 
resource-poor settings. Food and beverage companies are incorporating micronutrients into everyday food 
products. Similarly, media firms such as the Brazilian network, TV Globo, incorporate key health messages into 
their programming (see boxed example).
 – They explore new pricing strategies and alternative revenue streams that increase the affordability of health care. 
For example, many pharmaceutical firms, such as GSK, Sanofi Aventis, Pfizer, Merck, Novartis and others, offer 
tiered prices. These are determined by the ability to pay, which allows the companies to expand access among poor 
women and children without cannibalizing existing revenue.
Redefining productivity in their value chains
Companies generate profits by adding value to raw materials, products and services at each stage until they reach the 
consumer or end-user; this process is known as the value chain. In most cases, value chains are context-specific. So, a 
value chain that is profitable in North America may be unprofitable in most of Africa.
This is why it is important for companies to reconfigure their value chains to address the issue of women’s and 
children’s health in new markets. By adapting their value chains to local conditions, companies can often serve markets 
that would otherwise be out of reach, while also creating shared value. There are several ways in which firms can 
innovate to deliver products and services more widely and affordably:
 – They reconfigure design, development and production to lower costs or improve reliability of supply. For example, 
many pharmaceutical companies, such as Gilead, GSK and Sanofi Aventis, use local licensing and manufacturing 
agreements to lower production costs.
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Reconceive 
products and markets
Redefine productivity in 
value chains
Strengthen local
clusters
 –New products and services 
E.g. Bajaj Allianz provides health 
microinsurance
 –Adapted products and services 
E.g. TV Globo incorporates health 
messages into telenovelas
 –New pricing strategies / revenue streams 
E.g. GSK and Merck offer tiered pricing 
on drugs and vaccines
 –Reconfigured design, development and 
production 
E.g. Gilead Sciences licenses manufacturing 
of antiretrovirals to local Indian firms
 –New distribution and sales approaches 
E.g. Abbott True Care operates a sales 
force with local language skills to reach 
rural India
 –Services and after-sales support 
E.g. GA Insurance and Safaricom deliver 
financial services by mobile phone
 –Demand conditions for products and 
services 
E.g. Novartis runs an arms-length 
programme for community health 
education in India 
 –Contribute to health systems strengthening 
E.g. Becton Dickinson builds the capacity 
of laboratories in developing countries
 – Influence policy and standards 
E.g. Continua Health Alliance is developing 
new mHealth interoperability standards
Box 9
Three Levels of Creating Shared Value, with Illustrative Examples
 – They adapt or expand distribution and sales approaches to improve efficiency and increase market reach. Abbott 
and Novartis, for example, have both developed innovative distribution businesses – True Care and Arogya Parivar 
(see boxed example) – which allow them to sell health products in rural India.
 – They find more efficient ways to deliver services and after-sales support. For example, medical insurance provider 
Changamka in Kenya has partnered with Safaricom to provide payment services over mobile phones. 
Strengthening local clusters 
Clusters – the health systems, infrastructure, supporting industries, policies and social norms that surround business 
operations – are key to a company’s ability to operate viably over the long-term. It is difficult for companies to do business 
without such a supporting “ecosystem” of actors, particularly in such a complex field as health care. Companies can work 
in several ways to strengthen local clusters:
 – They seek to influence the demand conditions for products and services, such as cultural attitudes towards health 
and health seeking. For example, pharmaceutical and medical device firms support community health education 
services – such as Novartis through its Arogya Parivar initiative. Similarly, insurance companies support efforts to 
improve financial literacy, as Bajaj Allianz is doing with CARE.
 – They contribute to strengthening health systems to enable delivery of products and services. For example, IT firms 
such as Intel are investing in programmes to train health-care workers, who will eventually form a future customer 
base for their health-related products (see boxed example). Similarly, medical device companies such as Becton 
Dickinson and Roche are working to strengthen laboratory services in developing countries.
 – They contribute to the development of policies and standards, or seek to influence those already in force, in ways 
that can facilitate the uptake of beneficial products and services. For example, the Continua Health Alliance brings 
together more than 240 companies to develop technology standards for mHealth solutions, to ensure the 
interoperability of systems and devices.
Corporate philanthropy and CSR also play an important role
Core business activities may represent the most sustainable, long-term path for companies to deliver products and services that 
meet the large-scale health needs of women and children. However, corporate philanthropy and corporate social responsibility 
(CSR) can also play a critical role. In particular, philanthropy and CSR can help companies create shared value in two ways:
 – Complementing existing business activity by investing to strengthen local clusters. For example, Aspen Pharmacare 
already creates shared value by manufacturing and selling high-quality, affordable antiretrovirals and other key 
medicines. In addition, it is participating in an initiative led by the South African government, and involving a wide 
range of partners, to strengthen the South African health system. While this is a CSR initiative within the company, 
South Africa accounts for 50% of the firm’s sales, and the company also stands to benefit if more South Africans are 
able to access effective health care.
 – Incubating longer-term opportunities to create shared value. For example, the Medtronic Foundation has committed 
to Every Woman Every Child that it will invest US$ 1 million to support planning and advocacy activities around 
noncommunicable diseases. This is focused on the care and treatment of the most vulnerable people, including 
women and children. While this will not provide an immediate return to the company, it nevertheless aligns with 
Medtronic’s long-term business interest in growing the viable market for its products. 
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Key Partners Initiative Issue Needs Addressed 
Merck with PATH, US Government 
and various other governments and 
NGOs
Merck for Mothers  –Reduce the burden of maternal 
mortality (postpartum 
haemorrhage, preeclampsia)
 – Improve access to family planning 
 –Product innovation, improved access 
to preoven prevention and treatment 
services and advocacy and awareness
Hewlett-Packard with Roche, Clinton 
Access Initiative 
Early Infant Diagnosis  – Ineffectiveness of antiretroviral 
therapy due to long response 
time for test results
 – Technology to automate the HIV-testing 
process, data collection and reporting
Novartis with Vodafone, IBM, The 
Roll Back Malaria Partnership, 
Ministry of Health of Tanzania 
SMS for Life  – Shortage of anti-malaria 
medicines due to poor inventory 
systems
 –Mobile phones, SMS and electronic 
mapping technology to track weekly 
stock levels and distribution of inventory 
Johnson & Johnson, Voxiva, National 
Healthy Mothers, Healthy Babies 
Coalition (HMHB) in the US; in Russia, 
Johnson & Johnson, Voxiva, Health 
and Development Foundation, and 
Russian Federation Ministry of Health
Text4Baby  –Majority of women worldwide 
only have one prenatal visit with 
a health-care professional before 
giving birth
 – Free, stage-based text messages to 
deliver critical health information 
to new and expectant mothers in 
underserved communities
Johnson & Johnson with H4+ agencies 
(WHO, UNFPA, UNICEF, World Bank, 
and UNAIDS)
Strengthening Capacity 
for Maternal and 
Newborn Health
 –Critical shortage of health 
workers in Ethiopia and United 
Republic of Tanzania
 –Need to increase the percentage 
of facilities-based births
 –Training heath workers: nurses, 
midwives and general practitioners
 – Scaling up Maternal Death and 
Perinatal Audits
 – Encouraging clinical knowledge 
sharing among East African countries
Becton Dickinson, George W. Bush 
Institute, PEPFAR, Susan G. Komen 
for the Cure, Joint United Nations 
Programme on HIV/ AIDS (UNAIDS)
Pink Ribbon Red Ribbon  – Lack of access to cervical cancer 
prevention, diagnosis and 
treatment
 –Discounted pricing on vital cervical 
cancer diagnostic tests 
 – Education and training for laboratory 
staff and health-care workers on 
screening for cervical cancer
In addition, not all health needs – particularly those of the very poorest – are amenable to the shared value approach. In 
some cases, companies are deterred by persistent market failures. However, through philanthropy and CSR they can 
contribute to addressing these intractable problems.
Whether aimed at creating shared value or not, the most effective philanthropic and CSR approaches leverage unique skills, 
resources and expertise. These usually achieve more impact than simple cash or product donations. For example:
Internal investments in employees and their families
The private sector can, and has, contributed to women’s and children’s health through internal policies, such as workplace 
policies and various benefit systems. For example, many private enterprises have adopted successful HIV workplace 
policies to provide HIV prevention, treatment and care to their employees, often expanding to their dependants, as well 
as to ensure non-discrimination in the workplace. Beyond being important in their own right, these policies could serve 
as a template for workplace policies on maternal and child health. Moreover, benefits such as maternity/paternity leave, 
time off for antenatal and postnatal visits, and/or company health insurance can make significant contributions to 
women’s and children’s health.
Public policy dialogue and advocacy
Although it is not the focus of this guide to discuss opportunities for business in public policy and advocacy, it is 
important to mention that companies from various industry sectors, either individually or collectively, participate in 
health-related public policy dialogue and in a broad range of advocacy platforms with governments, multilateral 
organizations and civil society. Examples in women’s and children’s health include Every Woman Every Child and various 
related policy initiatives in countries. 
In all cases, partnerships are critical for success
Successful initiatives, whether seeking to create shared value or purely philanthropic, often need to address multiple 
gaps in the health landscape simultaneously. This can be achieved most effectively through partnership working. From 
an economic perspective, health-system gaps can constrain growth, so overcoming them may add costs and risk to 
initiatives. From a social perspective, women and children rarely face one issue in isolation: rather than improving 
health outcomes, initiatives that focus on just one issue risk simply changing the eventual cause of illness or death.
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It is rare for one company, organization or sector to have sufficient expertise and resources to be able to act effectively on 
all of these gaps on their own. Rather, successful initiatives often involve partners from multiple industries and sectors:
 – Governments – both national and local – play a critical role. They have a primary obligation to ensure that the public 
health needs of their populations are met, and are responsible for setting key priorities (often documented in a 
national health plan). Also, in many cases, only governments have the reach and scale to help initiatives reach those 
most in need. As a result, government involvement or endorsement of an initiative can be instrumental to its success.
 – Working with complementary industry sectors can allow participating companies to leverage each other’s core 
competencies to address multiple issues simultaneously; thereby creating new opportunities.
 – Civil society can bring key expertise in implementing initiatives. NGOs can help reach and involve sections of the 
community that may be essential to an initiative’s success, but which companies may have little experience of dealing 
with. Health-professional associations can advocate for the prioritization of women’s and children’s health nationally 
and internationally and for the implementation of essential interventions, setting standards and competencies, 
supporting continuing medical education for their members and ensuring regulation through processes such as 
accreditation. Academic institutions can provide training for health workers in highly specialized skills. They can 
drive research and support sophisticated analysis, such as monitoring changing disease burdens.
 – The United Nations and its specialized agencies, supported by member governments, have unique capacities. These 
include the ability to act as neutral brokers to convene different actors, to aggregate and disseminate data, to 
influence policies and to set norms and standards. Some of the key agencies influencing health include the World 
Health Organization (WHO), the United Nations Children’s Fund (UNICEF), the United Nations Population Fund (UNFPA), 
UNAIDS, UN Women and the World Food Programme (WFP). The World Bank can also play a similar role to reduce 
poverty and support development through financial products and services. 
 – Funding partners include bilateral aid agencies, multilateral organizations such as the International Finance 
Corporation (IFC), private foundations and innovative financing mechanisms such as UNITAID. These can play a 
role in bridging market failures, in seed-funding initiatives that may grow into self-sustaining models over time, 
or in providing critical growth capital where other financing may be hard to obtain.
 – Finally, global health partnerships and alliances (such as Roll Back Malaria, The Global Fund, Stop TB, PMNCH) can 
play an important catalytic role to facilitate cross-sector partnerships, open new avenues for dialogue and raise 
additional resources. For example, GAVI partners with the vaccine industry from developed and developing countries 
for innovative models in pricing and delivery of vaccines. It has also launched the GAVI Matching Fund to attract 
private sector funding and skills.
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In 2008, Intel recognized the opportunity to have a lasting impact on 
India’s acute shortage of health workers through its core products 
and a tailored marketing approach. The company played the 
role of a catalyst by delivering an undergraduate medical 
curriculum as high-quality digital content through India’s 
Digital Approach to Medical Education programme. 
In India, the shortage of health professionals is due 
mostly to the shortfall of faculty members to teach 
students. Also, the overall quality of health-care 
delivery, including health outcomes for women and 
children, is affected by the lack of uniformity in the 
standards of medical education across the country. 
Intel recognized early in the process that the complexity of the 
issue called for a more holistic approach than the initial plan to focus solely 
on content. A number of elements of the delivery system and enabling environment needed to be addressed to ensure 
the success of this venture. Intel therefore invested upfront to tackle issues such as awareness building, broadband 
infrastructure and management and faculty member education. In order to address each element of this fragmented 
health system and respond to local needs, Intel had gradually to build a dense network of partnerships by carefully 
selecting local partners in each region. Intra-industry partnerships were necessary to bring complementary skills to 
Intel and the medical content provider: telecom providers deliver the broadband connectivity; networking partners, 
including Cisco, support in setting up state-of-the-art networking infrastructure nationally; and software partners, 
including Microsoft, provide software support and access to media and database servers as well as digital rights 
managements. Cross-industry partnerships with financial institutions, including Bank of India, were also pursued to 
lend financial support to students and help them buy PCs. 
This programme brings ongoing value to the Indian health system by increasing the number of IT-enabled clinical 
professionals, thus making scarce clinical resources available to a larger unserved market. It also increases the capacity, 
productivity and quality of the medical education system through the 
harmonization of standards across the country. As for Intel, to date over 
90 000 students and faculty members and 410 clinical institutions are 
using this programme. With an annual increase of around 36 000 
beneficiaries, Intel has secured a promising customer base for 
its products in a high-growth market. The company is 
currently building on the success of the programme to expand 
the scope of medical areas covered, while simultaneously 
rolling it out to Philippines, Sri Lanka and Bangladesh. In 
addition to that, Intel made a commitment in Every Woman Every 
Child to scale education and training to 1 million health workers 
by 2015, working with several partners including the UN agencies 
under its 1Mx15 Health Initiative.
“ Technology will play an essential role in 
delivering health care to all citizens in the 21st 
century. Our new commitment 1Mx15 Health 
Initiative (educating 1 million health workers by 
2015) to Every Woman Every Child 
is an integral part of this effort. ” 
— Mike Gann, 
Director, Global Healthcare, Intel Corporation
INTEL – World Ahead Program for Medical Education
Issue: Acute shortage of health workers in India and lack of uniformity of standards of medical 
education across the country.
Partners: Bank of India, International Financing Corporation, MedRC EduTech – content developer, 
BSNL broadband provider, Cisco and Microsoft.
Examples of transformative partnerships:  
sustainable business models that are at scale or are scaling up
IFC
MedRC 
EduTechBSNL
Bank of 
India
INTEL
Microsoft
Cisco
www.intel.com/content/dam/www/public/us/en/documents/articles/world-ahead-global-healthcare-article.pdf
Health 
workers 
and medical 
education 
in India
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Lack of access to medicine causes millions of deaths in developing countries, 
especially among women and children. In 2007, Novartis decided to 
tackle this problem. It reached out to the underserved group of 
rural Indians earning between US$ 1 and US$ 5 per day with a 
sustainable and scalable pharmaceutical delivery business 
called Arogya Parivar (AP). 
While an estimated 65% of Indian people lack regular 
access to essential medicines, rural India is a massively 
underserved health market. It represents 70% of the 
population, but just 22% of all health spending. Part of the 
problem comes from low adoption rates. Even when health 
products and treatment are available, people often can’t 
afford them or don’t know they exist. 
Novartis recognized the need for a holistic approach to this complex 
problem. It chose to address all three elements of the health system (primary, 
secondary and tertiary) through its core competencies when possible, and through partnerships when not.
The company started by carefully analysing the local disease burden, and then developed a portfolio of 79 tailored 
products in 11 therapeutic areas. These were drawn from its originals, generics and over-the-counter businesses, 
alongside products from other firms such as Vestergaard Frandsen bed nets. It also set up tailored delivery systems to 
expand the reach of its products.
Novartis strove to meet the local demand for more affordable products by reducing packaging sizes and manufacturing 
locally. In parallel, it established a dense distributor network of local sales teams to provide access to crucial market 
intelligence and reduce mistrust among potential customers. However, the company found that the best strategy for 
successful uptake of its products was to work closely with India’s own health system. In partnership with the public 
sector, Novartis involved local key stakeholders in villages to educate the poor consumers on disease prevention and 
seeking timely treatments for ailments. It helped rural health practitioners and pharmacies to link up with microfinance 
institutions (MFIs). This enabled them to develop rural health-care capacity and ultimately saved patients long 
journeys into cities.
Novartis has shown leadership, and secured its presence in a key 
growth market, by venturing into communities where high 
logistical costs often deter companies. AP broke even after 
30 months and delivers needed health products in 33 000 
villages in 10 states in rural India, reaching a total 
population of 42 million. Novartis has ambitious plans 
for the future in the remaining states of India and has 
recently expanded the initiative to Kenya, and is expected 
to roll out in Vietnam and Indonesia in 2012.
“ In designing Arogya Parivar, 
meaning ‘healthy family’ in Hindi, 
we were trying to achieve what 
we call the three S’s: to be sustainable, 
have impact at scale, and do so with speed. 
We knew that unless we could give a proof 
of concept to the Novartis board quickly 
it would be impossible to move forward. We 
broke even in under 3 years. ”
— Anuj Pasrija, 
Head of Social Business Group, Novartis
Issue: 65% of India’s population lacks access to essential medicines.
Partners: Public sector at state and community level, over 20 NGOs, Vestergaard Frandsen, 
microfinance institutions.
NOVARTIS – Arogya Parivar for Access to Essential Medicines
Microfinance 
institutions
Vestergaard 
Frandsen
over 20 
NGOs
Public sector 
- community 
level
Public sector 
- state level
Novartis
Access to 
essential 
medicines 
in India
www.novartis.com/corporate-responsibility/access-to-healthcare/our-key-initiatives/social-business.shtml
23
Private Enterprise for Public Health. Opportunities for Business to Improve Women’s and Children’s Health.
Brazil’s public health system doesn’t always effectively reach the poorest 
segments of the population.12 However, since 1974 it has been helped by 
a major television company. By including social and health messages 
into its entertainment programmes, TV Globo has been using its 
position as a broadcaster to drive progress in the Brazilian health 
system, while also building its competitive advantage.
The decentralized health-care system established in 1988 in Brazil is still 
developing, as it seeks to enable universal and equitable coverage throughout 
the country. Health-sector reforms in Brazil are driven predominantly by civil society, so the challenge is ultimately 
political to secure the universal right to health.13 
TV Globo broadcasts to millions of Brazilians every day, so it is in a strong position to educate as well as entertain. For 
example, it has raised awareness of the need for early diagnosis of paediatric cancers, which has led viewers to pressure 
their local governments to enforce proper standards of care. The private TV network currently has 837 shows 
channelling social and health information to all segments of the population.
To build health information into its storylines, TV Globo works in partnership with government agencies, 
universities, NGOs and private companies. However, it accepts it is only a small part of the solution, because 
meaningful health impact can only come from the integrated work of multiple partners acting in parallel at different 
levels of the health system.
The issue of attribution makes it difficult for TV Globo to 
measure its social impact, but its access to over 45 
million viewers gives a sense of the scale. The 
returns for TV Globo itself are easier to 
establish, because the company’s 
commitment to social issues is an 
integral part of the strategy that has 
helped it capture more than 50% of 
Brazil’s TV market. This competitive 
advantage drives its credibility with investors 
and advertisers, and especially with the general 
public, which perceives TV Globo as a caring and 
socially concerned broadcaster.
“ Our commitment to social 
and education issues is TV Globo’s 
strongest differentiator from 
other media companies. ”
— Beatriz Azerado, 
Head of Social Projects, TV Globo
TV Globo – Social and Health Messaging
Issue: Lack of health services and health education for the poorest population in Brazil.
Partners: Government agencies, universities, NGOs, private network distributors.
NGOs Universities
Private 
network 
distributors
Government 
agencies
TV Globo
Health 
services and 
education  
in Brazil
http://redeglobo.globo.com/Portal/institucional/foldereletronico/ingles/g_rs_missao_social.html
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Telecommunications company Bharti Airtel is addressing Indian’s lack of 
access to health-care information by sending daily text messages to its 
customers on a variety of health issues. This is an important service, 
because many Indians are unable to get essential information due to 
taboos around topics such as sexual health, and problems with 
accessibility and affordability.
Bharti Airtel launched SMS-based health packs in 2011. Users pay a daily 
fee for subscriptions to receive information in four health areas: common 
health conditions, lifestyle diseases, men’s health and women’s health. This service 
built on its existing SMS-based information platforms (e.g. for sports results etc.), so the company incurred few 
development costs beyond content development. Bharti Airtel recognizes that, while it can reach phone subscribers, it 
does not have the expertise to develop appropriate content. As result, it is working with specialist content providers like 
mDhil that focus on translating public-health information into compelling, understandable messages with less than 160 
characters (thus suitable for dissemination via SMS). While the service currently focuses on urban areas, the company 
also recognizes the long-term potential of expansion into rural India, and notes it needs to partner with government in 
order to win the trust of rural consumers. 
The topics have been chosen based on consumer demand analysis. mDhil 
works closely with public health professionals, physicians and medical 
researchers to create content for services which empower users with 
accurate and culturally relevant health information for India. 
Given the lack of accessible health information – particularly for 
areas such as reproductive health – mDhil working with Bharti 
Airtel and partners enable users to make informed choices 
for positive health outcomes.
Early data about the service are promising. Bharti 
Airtel’s 30% market share represents a customer base 
of approximately 182 million; during the first year since 
launch, the company has already reached over 500 000 
customers through this new product. Women’s sexual 
health, traditionally a subject for which information is difficult to obtain, is one of the most popular products with 
women. The company has ambitious expansion plans for the service, aiming to reach 8%-10% of its subscriber base by 
the end of 2013 – an estimated 15-20 million customers.
“ Our view is that there is an 
opportunity in mHealth; therefore 
this is of importance to us. But it is 
only going to happen if we can 
form requisite partnerships. ”
— Mohit Beotra, 
Bharti Airtel
BHARTI AIRTEL – SMS-Based Health Information Packs
Issue: Lack of access to health-care information in India.
Partners: Private content providers e.g. mDhil, local governments.
Local 
governments
Private 
content 
providers 
BHARTI 
AIRTEL 
Health-care 
information 
in India
www.airtel.in/wps/wcm/connect/Airtel.in/airtel.in/home/whats+new/pg-mhealth
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Safaricom - Helping to Spread the Cost of Health Care
Kenyan telecommunications company Safaricom is helping poor 
people budget for the costs of health care through its 
electronic payment system M-PESA. The scheme is 
part of the company’s commitment to work with 
the Kenyan Government and other partners to 
build the enterprise architecture needed for 
mHealth solutions at national scale. According 
to Bob Collymore, the company’s CEO and a UN 
Global Compact Board Member: “Safaricom is a 
perfect illustration of an industry outside the traditional 
‘health sector’ that makes a significant contribution to 
improving women’s and children’s health.”
Launched in March 2007, M-PESA grew within five years to have more than 14.8 million customers and about 35 000 
agent outlets countrywide. More than 700 organizations now accept bill payment via M-PESA and a further 300 are bulk 
payment partners. M-PESA account holders can buy electronic funds at an M-PESA agent and send the electronic value 
to any other mobile phone user in the country, who can then redeem it for conventional cash at any M-PESA agent. The 
service does not require users to have a bank account – an important consideration in Kenya, where millions of people 
do not have them.
The success and widespread availability of M-PESA makes it an ideal way for users to save money for medical expenses. 
To this end, Safaricom linked up with Changamka, the Kenyan medical insurance provider. By combining their expertise 
in different fields, and working alongside health-care providers equipped to use the M-PESA system, the two companies 
are helping poor people meet the costs of health care. A Kenyan mother may be able to afford a few dollars for 
treatment for her baby if she can spread the payment out over time, or easily get help from her family in another part of 
the country, but not if she has to pay in cash all in one go. Innovative payment systems like this can put more health 
services within reach of the poor.
M-PESA is just one example of shared value through 
communications technology. Safaricom aims to encourage 
other African businesses, especially mobile phone 
providers in other countries in Africa, to match 
its commitment to the United Nations 
Secretary-General’s Global Strategy. Mr 
Collymore said: “In a world with over 5 
billion mobile phone users, and a rapidly 
growing broadband network, there are many 
other opportunities, particularly in developing 
countries. Every company can make a difference.”
Issue: Need for innovative payment system for health services for the poor.
Partners: Government of Kenya, Changamka - medical insurance provider, private and public 
health providers.
“ I like the idea of cross-industry collaboration. 
We don’t have the credentials to push the 
health agenda forward alone, so we need to 
work with partners such as large hospitals in 
the execution of these initiatives. ”
— Bob Collymore, 
CEO, Safaricom, 
UN Global Compact Board Member
Changamka Private health 
providers
Government 
of Kenya
Innovative 
payment 
system  
for health 
services
Safaricom
Public health 
providers
www.safaricom.co.ke/index.php?id=250 and http://changamka.co.ke/
“ The current challenges our economy and our planet 
are facing require new partnerships. No one sector 
can solve them alone. These partnerships reflect new 
business models, and are helping us provide solutions 
to big social and environmental problems in a way 
that is equitable, sustainable and drives growth. ” 
— Paul Polman,  
CEO, Unilever, UN Global Compact LEAD Task Force Co-Chair
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4. A blueprint for action: collective impact
Actors from 
several sectors 
& industries…
…align and 
coordinate 
their efforts…
…to innovate 
around a set of 
related issues…
…in one 
specific 
location...
…to create 
shared 
value
Actors from 
several sectors 
& industries…
…align and 
coordinate 
their efforts…
…to innovate 
around a set of 
related issues…
…to create 
shared 
value
Figure 10
A Vision for collective impact for women’s and children’s health
Box 11
Example: The Beira Agricultural Growth Corridor in Mozambique
Problem: 10 million hectares of arable land largely untapped due to poor access to agriculture-supporting infrastructure, 
lack of suitable finance and insufficient experienced agriculture entrepreneurs and senior managers.
 – 34 international and local private sector actors from the Financial Services, Agribusiness, 
Energy/Electricity and Mining industries;
 – 12 Donors/DFIs (e.g. ADB, WB, IFC, USAID);
 – 4 NGOs (e.g. TransFarm Africa, TechnoServe, NEPAD Business Foundation);
 – 4 Government of Mozambique Agencies.
 – The Beira Agricultural Growth Corridor Partnership (participants from the private 
sector, government and the international community) and a secretariat to coordinate 
stakeholder action;
 – InfraCo implements infrastructure development projects; AgDevCo supports small and 
medium size ventures.
 – Increase commercial investment in agribusiness
 π Supporting infrastructure: Electricity grid connections, water supply for irrigation and 
feeder roads to connect farms to the trunk infrastructure;
 π Input supply chain: Fertilizer, seeds;
 π Access to markets: Storage, wholesale markets, roads, railways, ports, etc;
 – Clustering of agribusiness to reduce costs, improve access to inputs and markets.
 – It is estimated that at least 200 000 small-scale farmers will benefit directly from improved 
yields and increasing incomes, creating 350 000 new jobs and helping move up to 1 million 
people out of extreme poverty;
 – This expanded customer base will translate into increased economic returns for the 
companies involved in the project.
Collective impact could transform health and create new opportunities
As economies develop and health systems improve over the next few years, companies can find and pursue shared value 
and philanthropic opportunities as they open up. However, they don’t need to wait. Through collective impact – mutually 
reinforcing efforts across several industries and sectors to transform health systems in a specific location (see Figure 10)14 
– they can “change the game” on women’s and children’s health, proactively creating the opportunities of tomorrow.
Examples of collective impact in global health are emerging. However, one of the most successful and best documented 
examples of this kind of activity comes from agriculture. The Beira Agricultural Growth Corridor is a good example of 
collective impact in action (see boxed example 11). The initiative aims to stimulate a major increase in agricultural 
production on 10 million hectares in central Mozambique, and transform the lives of more than 1 million local people. 
It was launched in 2009 by a coalition of 54 actors, including the government of Mozambique, the international 
community and 34 companies.15
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Successful collective impact initiatives require several key ingredients
Working in this way can be challenging for companies. If they fail to analyse their situation and opportunities 
thoroughly, and chose inappropriate partners, companies can risk making mis-steps or being distracted from their core 
business. Competitive considerations may make it complicated – both from a cultural and a legal perspective – to 
partner with other firms. Similarly, a mutual lack of understanding and trust can hamper efforts to partner with the 
public sector, NGOs and multilaterals. Lack of alignment on interests and goals can damage partnerships, and may risk 
producing counterproductive results. Finally, short time horizons and overambitious goals can lead to disappointment. 
As with any commercial opportunity, it takes time and effort to build new markets.
Successful collective impact initiatives address these challenges by incorporating several “best practices”:
Collective impact for women’s and children’s health: what could be achieved?
Collective impact in global health and development is still relatively new – the Beira Agricultural Growth Corridor, one 
of the more developed examples, is still less than three years old. So, while some efforts are being planned or piloted, 
including several led by United Nations agencies, research for this guide did not uncover any global health examples 
involving companies that had reached scale.
However, by considering different innovations currently being pursued by various companies, it is possible to imagine 
what a collective impact initiative might look like. An example is presented on the next page.
1. Multiple industries and sectors are involved
 – Few organizations have the competence or legitimacy to be able to act efficiently on multiple areas simultaneously;
 – Therefore, successful initiatives will include multiple partners from different industries, and across the public and 
private sectors.
2. Partners work toward a common agenda, based on rigorous analysis
 – To be effective, partners need to be aligned on what success looks like, and on their respective interests and motivations;
 – This should be rooted in the relevant country-led health plan;
 – Companies should conduct thorough market analysis to identify opportunities and develop strategies. 
3. Action is differentiated but mutually reinforcing
 – Rather than pooling resources in one agency, or duplicating efforts, actors should focus on their core competencies;
 – These differentiated efforts should be mutually reinforcing;
 – A clear “division of labour” can also help build trust.
4. Partners use shared metrics to track progress and to learn
 – Shared metrics help ensure that the different efforts add up to the overall vision, and enable cross-sectoral learning;
 – Metrics need to be defined at the start, with a baseline, so that all partners can use them as a management and 
learning tool.
5. There is continuous communication between partners
 – Consistent and open communication is needed to maintain alignment and trust;
 – Companies do not need to reveal competitive information, but do need to signal intentions and progress to 
relevant partners.
6. The initiative is coordinated by a “backbone organization”
 – To implement the above, a common resource is needed to broker partnerships, and to coordinate planning, 
communication and measurement;
 – Such a “backbone organization” needs appropriate skills, resources and operational independence to be effective. 
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Achieving collective impact in a medium-sized country*
 – Population: 30 million people
 – GDP (2010): US$ 55 billion, growing at 5.5% per year
 – Annual Health Spending: US$ 0.6 billion, growing at 9.7% per year; 60% private funded
 – Key Health Issue: deaths from three key childhood diseases at 5x regional average
 – Industry Partners: Pharmaco; MedTech, Inc.; ITCo; Dianhua Phone Company; Resseguro Nacional; National Bank 
Pte. Ltd.; Svasthya Films; Vifaa Industries
 – Public Sector & Civil Society: Ministry of Health, Fondation Stéphane Soumano (FSS), DevNet, KidsHealthNow, 
National TV, National Memorial University, World Health Organization (WHO)
 – Pharmaco and MedTech, Inc. work with 
Ministry of Health to train paediatric health 
workers at the National Memorial University
 – Uses curriculum developed by National 
Memorial University and WHO via ITCo 
e-learning software
 – Pharmaco builds a 
distribution 
network, incl. new 
cold chain supplied 
by Vifaa Industries
 – MedTech, Inc. 
partners with ITCo 
and Dianhua Phone 
Co. to send 
diagnostic results 
to lab for analysis
 – Pharmaco develops 
new drugs for 3 key 
local childhood 
diseases, of which 
one with a product 
development 
partnership,  
co-funded by FSS
 – MedTech, Inc. 
develops rapid 
diagnostics that it 
bundles with related 
Pharmaco products
 – ITCo and Dianhua Phone Co. leverage 
the remote diagnostic system to send 
epidemiology data to the Ministry of 
Health to guide planning, with funding 
from the FSS and technical support 
from WHO
 – Building on the epidemiology data, 
Pharmaco and FSS work with the 
Ministry of Health to advocate for 
increased donor financing
 – Insurance company Resseguro Nacional 
works with global development NGO, 
DevNet and National Bank to develop 
microinsurance for children aged 0-5; 
subsidized by the Ministry of Health to 
reach families earning <US$2 per day
 – National Bank also works with Dianhua 
Phone Co. to extend its mobile payment 
services to local clinics
 – Dianhua Phone Co., partners with WHO 
and NGO KidsHealthNow to send new 
mothers information on infant health via SMS
 – Svasthya Films produces a soap opera 
featuring child health storylines, which is 
broadcast on National TV
*Company names are fictional
“ This guide is a very helpful tool. 
Now it is important how it will  
be used and how we’ll catalyse 
collective action and create shared 
value together with women and 
children in the countries. ” 
— Julio Frenk,  
Dean, Harvard School of Public Health, 
PMNCH Board Chair
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5. Next steps: the time to act is now
Key Questions to Answer Useful Resources
1. Identify 
opportunities
 – Which developing country markets are priorities 
for your company in short- or longer-term?
 – What are the biggest and most persistent health 
needs of women and children? What are the 
priorities set out in the national health plan?
 – Which of these needs is your company best 
positioned to address, given your core 
competencies?
 – Section 2 of this guide;
 – National Health Plans (contact the relevant Ministry 
of Health);
 – Essential Interventions, Commodities and Guidelines 
for Reproductive, Maternal, Newborn and Child Health 
(see http://portal.pmnch.org);
 – Countdown to 2015 (www.countdown2015mnch.org), 
see summary of Women’s & Children’s Health: Needs 
& Challenges (annex of this guide);
 – Priority commodities (see The UN Commission on 
Life-Saving Commodities for Women and Children).
2. Prioritize 
and build the 
business case
 – What is the size of the market or target population? 
What are the market dynamics (e.g. public vs. 
private health spend, etc.)?
 – What is the state of the health cluster? What 
critical gaps exist?
 – What is the scale of investment likely to be 
required, and how does this compare with 
potential social and business impact?
 – National Health Plans (contact the relevant Ministry 
of Health);
 – WHO National Health Accounts (see www.who.int/nha/); 
 – For example GSMA IMEI Database for mobile telephone 
industry (see http://imeidb.gsm.org);
 – To learn about other firms’ experiences, contact the 
Innovation Working Group in support of Every Woman 
Every Child (see www.everywomaneverychild.com/iwg).
3. Explore 
partnership 
options
 – What existing initiatives are operating, which 
your company may be able to join?
 – What complementary industries are needed to 
bridge gaps in the cluster, or to enable 
implementation of an initiative?
 – What expertise or competencies from the public 
sector and civil society are needed? Who could 
play that role?
 – Who can broker and coordinate partnerships?
 – To connect with other companies and other stakeholders 
focused on women’s and children’s health, contact 
PMNCH (see www.pmnch.org) and join the Innovation 
Working Group (email: iwg-pmnch@who.int);
 – For more information on United Nations system and 
public-private partnerships, contact the United 
Nations Foundation and the Global Compact 
(see www.unfoundation.org and www.unglobalcompact.org)
 – For calendar of key global, regional and local events, 
see www.everywomaneverychild.org
Whether your company is pursuing a comprehensive shared value strategy around women’s and children’s health, or 
contributing in a more modest way, you can register your commitment as part of the Every Woman Every Child effort. 
New commitments should represent policy, service or product delivery, and new financial commitments should aim to 
improve women’s and children’s health and address the needs outlined in the Global Strategy.
To find out more about making a commitment to Every Woman Every Child, please visit the website at: 
www.everywomaneverychild.org
With the 2015 deadline to achieve the Millennium Development Goals fast approaching, the time to act is now. To explore 
and develop options, companies should take three steps:
1. Identify opportunities related to specific needs and markets where they may be well placed to act in support of 
national health plans;
2. Prioritize and build the business case for the opportunities that make most sense in light of the company’s strategy 
and local health needs;
3. Explore partnership opportunities with complementary industries, government, the United Nations system and/or 
civil society as needed. In particular, companies should identify whether they can engage with existing efforts 
before launching a new initiative.
The table below shows the key strategic questions companies need to answer in order to develop an effective approach 
and useful resources and information sources to get started.
Methods
This document was discussed and developed based on interviews with 41 stakeholders drawn from 28 international 
companies, governments, foundations, multilateral organizations, NGOs and academia, who are actively engaged in 
global health and development or made commitments to the Every Woman Every Child effort. 
In addition, we conducted an in-depth literature search of key publications related to women’s and children’s health and 
the role companies have in this space. As part of this process, we reviewed more than 70 corporate initiatives in 
women’s and children’s health, and utilized various databases, case studies and resources to draw on information 
within the public domain (see references for more information). 
This guide was further informed by extensive consultations with businesses and all other key stakeholder groups in 
global health (see Acknowledgements). The consultation held during the 2012 World Economic Forum in Davos, 
Switzerland, brought together over 25 leaders from the private sector, NGOs and United Nations agencies to provide 
feedback on the first draft of this guide. Others consulted included the members of the Innovation Working Group in 
support of Every Woman Every Child, the United Nations Private Sector Focal Points from UNICEF, WHO, UNFPA, 
UNAIDS and UN Women and the United Nations Global Compact. The draft guide was then shared with the executive-
committee Board Members of the Partnership for Maternal, Newborn & Child Health (PMNCH) and with representatives 
of the seven PMNCH key constituencies (representing the 460+ members).
This guide was written and prepared for publication in July 2012 and the information contained was believed to be accurate 
at that time. Any opinions stated are those of the authors, unless otherwise indicated. 
Ju
n
e 
21
-2
2,
 2
01
1
In New York, 
USA: 
Presentation of 
the Guide at 
the Innovation 
Working Group 
meeting at the 
Columbia 
University
Oslo, Norway: 
Innovation Working 
Group meeting: 
members agree to 
commission 
development of a 
private sector 
engagement guide 
in support of Every 
Woman Every Child. 
(New African 
Connections Summit– 
Opportunities when 
Technology, Finance 
and Healthcare meet)
In New York, 
USA: Harvard 
Club Private 
Sector 
Luncheon 
Consultation 
- Innovating for 
Every Woman 
Every Child: 
“Towards 
sustainable 
partnerships 
and business 
models”
In New York, 
USA: Every 
Woman Every 
Child – new 
commitments 
announced to 
Every Woman 
Every Child 
including 
several from 
the private 
sector
UN General 
Assembly 
adopts 
resolution 
“Towards 
Global 
Partnerships” 
to accelerate 
UN-business 
partnerships
Consultation 
with the 
Innovation 
Working Group 
for Every 
Woman Every 
Child 
(Teleconference)
In Davos, 
Switzerland: 
Special 
consultation at 
the World 
Economic 
Forum, 
“Opportunities 
for growing 
business and 
improving 
women’s and 
children’s 
health”
Discussion with 
the PMNCH 
Executive 
Committee based 
on stakeholder 
consultations 
(Teleconference)
Consultation 
with the 
United Nations 
Private Sector 
Focal Points 
(Teleconference)
In Vienna: 
Meeting of the 
United Nations 
Private Sector 
Focal Points and 
Global Compact 
LEAD Task Force 
including several 
companies 
D
ec
em
b
er
 1
, 2
01
1
Ja
n
u
ar
y 
19
, 2
01
2
Fe
br
u
ar
y 
14
, 2
01
2
M
ar
ch
 2
8-
29
, 2
01
2 
20
12
Se
p
te
m
b
er
 2
1,
 2
01
1
Se
p
te
m
b
er
 2
1,
 2
01
1
Ja
n
u
ar
y 
27
, 2
01
2
M
ar
ch
 7
, 2
01
2
A
pr
il 
25
, 2
01
2
Consultations and key events in 
development of the guide
32
2011 2012
In London, 
UK: 
Launch of 
the guide 
at Family 
Planning 
Summit
Ju
ly
 1
1,
 2
01
2
Launch  
of the UN 
Commission 
on Life –Saving 
CommoditiesM
ar
ch
 2
3,
 2
01
2
33
Private Enterprise for Public Health. Opportunities for Business to Improve Women’s and Children’s Health.
References
Every Woman Every Child
 – Commission on Information and Accountability for Women’s and Children’s Health. Keeping promises, measuring 
results. Geneva, World Health Organization, 2011: http://www.who.int/topics/millennium_development_goals/accountability_
commission/Commission_Report_advance_copy.pdf
 – Every Woman Every Child. Innovating for Every Woman Every Child. Thematic Report: The Global Campaign for the Health 
Millennium Development Goals 2011. Ministry of Foreign Affairs, Norway, 2011: http://www.who.int/pmnch/activities/
jointactionplan/innovation_report_lowres_20110830.pdf
 – Every Woman Every Child. Saving the lives of 16 million. September 2011 Update: Global Strategy for Women’s and Children’s 
Health: www.everywomaneverychild.org 
 – Every Woman Every Child. The Global Campaign for the Health Millennium Development Goals 2011. Thematic Report: 
Innovating for Every Woman Every Child. Ministry of Foreign Affairs, Norway, 2011.
 – Every Woman Every Child. The Global Campaign for the Health Millennium Development Goals 2011. Putting the Global 
Strategy for Women’s and Children’s Health into action. Ministry of Foreign Affairs, Norway 2010.
 – United Nations Secretary-General. Global Strategy for Women’s and Children’s Health. New York, United Nations, 2010: 
http://www.who.int/pmnch/topics/maternal/201009_globalstrategy_wch/en/index.html
 – PMNCH. Analysing Commitments to Advance the Global Strategy for Women’s and Children’s Health. Geneva, 2011: 
http://www.who.int/pmnch/topics/part_publications/2011_pmnch_report/en/
 – PMNCH. RMNCH Knowledge Portal: http://portal.pmnch.org/knowledge-summaries
 – UN Commission on Life-Saving Commodities for Women and Children: http://www.everywomaneverychild.org/resources/
un-commission-on-life-saving-commodities
Case Studies 
 – Asian Development Bank. Investing In Maternal, Newborn And Child Health. The Case for Asia and the Pacific, Manila, 2009: 
http://beta.adb.org/publications/investing-maternal-newborn-and-child-health-case-asia-and-pacific
 – Abbott Healthcare: http://truecare.in/ptruecare/jsp/loginwho-we-are.do?parameter=ABOUT_ABBOTT
 – Aspen: http://www.aspenpharma.com/
 – BD. BD’s Global Health Initiative: http://www.bd.com/globalhealth/initiative/
 – Beira Agricultural Growth Corridor: http://www.beiracorridor.com/
 – Behringer Ingelheim. Viramune® (nevirapine) prolonged-release once-daily formulation for the treatment of HIV-1 infection 
receives approval in the EU. Press Release Archive, 2011: HIV AIDS: http://www.boehringer-ingelheim.com/news/news_releases/
press_releases/2011/21_september_2011nevirapine.html
 – Berg M, Wariero J and Modi V. Every Child Counts: The use of SMS in Kenya to support the community based management 
of acute malnutrition and malaria in children under five. ChildCount+, 2009: http://www.childcount.org/reports/ChildCount_
Kenya_InitialReport.pdf
 – Borgonovi V et al. Creating Shared Value in India: How Indian Corporations Are Contributing to Inclusive Growth While 
Strengthening Their Competitive Advantage. Boston, FSG, 2011: http://www.fsg.org/tabid/191/ArticleId/493/Default.aspx?srpush=true
 – The Hindu. Gilead Sciences in deal with 4 Indian drug cos. 12 July, 2011: http://www.thehindubusinessline.com/companies/
article2221311.ece
 – Changamka Microhealth: http://changamka.co.ke/
 – Care International. Maternal Health: The Power of Partnership. Findings from the CARE Learning Tour to Bangladesh. 
Washington DC, 2011: http://www.care.org/getinvolved/LearningTour/Bangladesh-Learning-Tour-Trip-Report.pdf
 – Continua Health Alliance, 2010: http://www.continuaalliance.org/index.html
 – DMI. Window to Love. 2009: developmentmedia.net/success.html
 – DSM. Hidden Hunger. 2011: http://www.dsm.com/en_US/cworld/public/media/pages/kit_2_hidden_hunger.jsp?download-file-
url=http%3A%2F%2Fwww.dsm.com%2Fen_US%2Fcworld%2Fpublic%2Fmedia%2Fdownloads%2Fpublications%2Fhidden_hunger.pdf%3
Ffileaction%3DopenFile&download-file-option=openFile&download-file-submit=OK 
34
 – Peterson K et al. Competing by Saving Lives: How Pharmaceutical & Medical Device Companies Create Shared Value In Global 
Health. Boston, FSG, 2012: http://www.fsg.org/tabid/191/ArticleId/557/Default.aspx?srpush=true
 – GAVI Matching Fund: http://www.gavialliance.org/funding/give-to-gavi/gavi-matching-fund/
 – GE. Healthymagination. 2012: http://www.healthymagination.com
 – Great Connection. Orascom Telecom, Mobinil and Great Connection Collaborate to Launch Mobile Baby™ Service in Egypt. 
2011: http://www.greatconnection.se/storage/documents/pressreleases/20110215_EgyptPressrelease.pdf
 – Gilead Sciences. Achieving Sustainable Access to HIV/AIDS Medicines in the Developing World. 2012: http://www.gilead.com/pdf/
access_fact_sheet.pdf 
 – de Graft-Johnson J et al. The maternal, newborn, and child health continuum of care. In: Lawn J and Kerber K eds. 
for PMNCH. Opportunities for Newborns: Practical Data, Policy and Programmatic Support for Newborn Care in Africa. 
Geneva, 2006.
 – GSK. Access to Vaccines. Corporate Responsibility Report, 2010: http://www.gsk.com/responsibility/cr-report-2010/access-to-
medicines/vaccines/
 – GSMA (GSM Association). Women & Mobile: A Global Opportunity – A study on the mobile phone gender gap in low and middle-
income countries. London, 2011: http://www.mwomen.org/Research/women-mobile-a-global-opportunity_1
 – Haupt S and Krämer A. Bringing Medicines to Low Income Markets: A guide to creating inclusive business models for 
pharmaceutical companies. Berlin, Endeva Enterprise Solutions for Development, 2012: http://www.medicines-for-bop.net/report/
 – Health Market Innovations. PhilHealth Remittance-By-Air. 2012: http://healthmarketinnovations.org/program/philhealth-
remittance-by-air
 – Hindustan Unilever. India: Swashthya Chetna. 2012: http://www.lifebuoy.com/swasthya_chetna.html
 – HP (Hewlett-Packard). Early Infant Diagnosis. Case study, 2011: http://www.hp.com/hpinfo/globalcitizenship/society/case_
study_early_infant_diagnosis.html
 – HP (Hewlett-Packard). HP Launches Global Authentication Service to Fight Counterfeit Drugs. 2011: http://www.hp.com/
hpinfo/newsroom/press/2011/110803xa.html 
 – IFPMA (International Federation of Pharmaceutical Manufacturers & Associations). Women’s & Child Health 
Partnerships for the Developing World. Geneva, 2011: http://www.ifpma.org/fileadmin/content/Publication/IFPMA_Woman___
Child_Health_Partnerships_2011.pdf
 – Intel. A Digital Approach to Medical Education. White Paper, Intel World Ahead Healthcare, Digital Healthcare Education, 2009: 
www.intel.com/content/dam/www/public/us/en/documents/articles/world-ahead-global-healthcare-article.pdf
 – Johnson & Johnson. Text4baby Announces Plans to Reach One Million Moms. 2010: http://www.jnj.com/connect/news/all/
Text4baby-Announces-Plans-to-Reach-One-Million-Moms
 – Kunzemann T. Microinsurance Band Aid. Allianz Knowledge Site, 2009: http://knowledge.allianz.com/microfinance/
microinsurance/?166/micro-health-insurance-india
 – Lifespring Maternity Hospitals. 2011: http://www.lifespring.in/
 – Medtronic Foundation. 2012: http://www.medtronic.com/foundation/
 – Merck. Merck Vaccine Network Africa. 2011: http://www.merckresponsibility.com/priorities-and-performance/access-to-health/
community-investment/public-and-private-partnerships/merck-vaccine-network-africa/home.html
 – Merck for Mothers. 2012: http://www.merckformothers.com/home.aspx#2
 – MobiHealthnews. mDhil, Indiagames bring health content to Airtel. 2011: http://mobihealthnews.com/11309/mdhil-indiagames-
bring-health-content-to-airtel/
 – National Bureau of Asian Research. The Potential of Technology to Transform Maternal and Newborn Health: Reflections 
from a Gathering of Unlike Minds. Seattle, 2011: http://www.healthynewbornnetwork.org/resource/qa-potential-technology-
transform-maternal-and-newborn-health-developing-world
 – Novartis Global. Social Business Initiative, Arogya Parivar. 2011: http://www.novartis.com/corporate-responsibility/access-to-
healthcare/our-key-initiatives/social-business.shtml
 – Rede Globo. 2012: http://redeglobo.globo.com/
 – Roche. AmpliCare. 2012: http://www.roche.com/corporate_responsibility/patients/access_to_healthcare/developing_countries/
amplicare.htm
 – DSM Nutrition Improvement Program. Unlocking Human Potential. Basel, 2012. http://www.nutritionimprovement.com/pdf/
nip_image.pdf
35
Private Enterprise for Public Health. Opportunities for Business to Improve Women’s and Children’s Health.
 – Sanofi Aventis. 2011: http://www.sanofi-aventis.in/l/in/en/index.jsp
 – Shah S. Health Microinsurance Models. ThinkChange India, 2008: http://www.thinkchangeindia.org/2008/09/03/health-
microinsurance-models/
 – Siemens . Siemens Pocket Ultrasound. 2012: http://www.medical.siemens.com/webapp/wcs/stores/servlet/PSGenericDisplay~q_
catalogId~e_-11~a_langId~e_-11~a_pageId~e_77978~a_storeId~e_10001.htm
 – Sproxil: http://sproxil.com/
 – The Times of India. LeapFrog buys 10% in Shriram CCL. 8 September, 2011: http://articles.timesofindia.indiatimes.com/2011-09-
08/india-business/30130120_1_insurance-group-south-african-insurer-investment
 – UNAIDS. Born HIV free Campaign. 2012: http://www.unaids.org/en/resources/presscentre/featurestories/2010/may/20100519gflaunches/
 – United Nations Population Division: http://www.un.org/esa/population/
 – Vodafone. SMS for Life. 2012: http://mhealth.vodafone.com/global/solutions/access_to_medicine/supply_logistics_safety/malaria/index.jsp 
 – World Economic Forum and the mHealth Alliance. Amplifying the Impact: Examining the intersection of Mobile Health and 
Mobile Finance. Geneva, 2011: http://www3.weforum.org/docs/WEF_HE_IntersectionMobileHealthMobileFinance_Report_2011.pdf
Other references
 – Axelson H, Bustreo F and Harding A. Private Sector Participation in Child Health - A Review of World Bank Projects, 1993–2002. 
Washington DC, The World Bank, 2003.
 – Barros AJD et al. Brazil: Are Health and Nutrition Programs Reaching the Neediest? Washington DC, The World Bank , 2005.
 – Bulloch G, Lancy P and Jurgens C. Convergence Economy: Rethinking International Development in a Converging World, 
Accenture, 2011: http://www.accenture.com/SiteCollectionDocuments/PDF/Accenture_Development_Partnerships_Rethinking_
International_Development_in_a_Converging%20World.pdf
 – GAVI. Merck Vaccine Network-Africa, Program Overview. 12th GAVI Board Meeting— 9-10 December, 2003, Geneva: 
http://fr.gavialliance.org/resources/12_board_MVN_A.pdf
 – GSMA (GSM Association) IMEI (International Mobile Equipment Identity) Database: http://imeidb.gsm.org
 – Surendra G, George CK and Pattnaik GS. Medium Term Expenditure Framework For Health, 2008-09 to 2012-13. Hyderabad, 
Institute of Health Systems, 2009: http://www.cgg.gov.in/publicationdownloads/mar03/MTEF_AP_20008_09_2012_13_FinalReport.pdf
 – International Business Leaders Forum. Investing in Women’s and Children’s Health. A primer on the contribution of the 
private sector as a partner in the Global Strategy on Women’s and Children’s Health. Working document, New Delhi, 2010.
 – International Finance Corporation. The Business of Health in Africa: Partnering with the Private Sector to Improve People’s 
Lives. Washington DC, 2012: http://www.ifc.org/ifcext/healthinafrica.nsf/AttachmentsByTitle/IFC_HealthinAfrica_Final/$FILE/IFC_
HealthinAfrica_Final.pdf
 – Kania J and Kramer M. Collective Impact. Stanford Social Innovation Review, vol. 9, no.1, 2011: http://www.ssireview.org/
articles/entry/collective_impact 
 – Kevbes KJ et al. Continuum of Care for Maternal, Newborn and Child Health: From slogan to service delivery. Lancet, 
vol. 370, no. 9595, 13 October 2007, p.1360.
 – Kinney MV et al. (on behalf of the Science in Action: Saving the lives of Africa’s mothers, newborns, and children 
working group). Sub-Saharan Africa’s Mothers, Newborns, and Children: Where and Why Do They Die? PLoS Med. 7(6): 
e1000294, June 2010.
 – Nelson J and Prescott D. Business and The Millennium Development Goals. A Framework for Action (2nd edition). 
London, International Business Leaders Forum, 2008.
 – Paim J. The Brazilian health system: history, advances, and challenges. Lancet, vol. 377, no.9779, 21 May 2011, pp1778-1797. 
 – Porter M and Kramer M. Creating Shared Value, How to Fix Capitalism and Unleash a New Wave of Growth. Harvard 
Business Review, January/February 2011: http://www.fsg.org/tabid/191/ArticleId/241/Default.aspx?srpush=true 
 – PMNCH and University of Aberdeen. Knowledge Summaries. 2010: http://www.who.int/pmnch/topics/part_publications/
knowledge_summaries_introduction/en/index.html
 – The Global Compact, Unilever, Dalberg. Catalyzing Transformational Partnerships between the United Nations and 
Business. New York, 2011: http://dalberg.com/sites/dalberg.com/files/Catalyzing%20Transformational%20Partnerships.pdf
 – Scaling Up Nutrition (SUN) web portal: http://www.scalingupnutrition.org
 – The Global Fund. MNCH Practical Guidance Tool. Strengthening support for maternal, newborn and child health within 
Global Fund proposals. Geneva, 2011: http://www.theglobalfund.org/en/application/otherguidance/
36
 – The World Bank, IFC. Healthy Partnerships. How Governments Can Engage the Private Sector to Improve Health in Africa. 
Washington DC, 2011: http://www1.ifc.org/wps/wcm/connect/industry_ext_content/ifc_external_corporate_site/industries/
health+and+education/news/features_health_healthypartnerships 
 – World Health Organization and UNICEF. Countdown to 2015 decade report (2000–2010): taking stock of maternal, newborn 
and child survival. Geneva, 2010: http://www.countdown2015mnch.org/
 – World Health Organization, The Aga Khan University, PMNCH. Essential Interventions, Commodities and Guidelines for 
Reproductive, Maternal, Newborn and Child Health. Geneva, 2011: http://www.who.int/pmnch/topics/part_publications/essenti
alinterventions14_12_2011low.pdf
 – World Health Organization. Compendium of New and Emerging Health Technologies. Geneva, 2011: http://whqlibdoc.who.
int/hq/2011/WHO_HSS_EHT_DIM_11.02_eng.pdf
 – World Health Organization. National Health Accounts: www.who.int/nha/ 
 – Women Deliver. Focus on 5: Women’s Health and the MDGs. New York, 2011: www.womendeliver.org
 – Access to Medicine Index: http://www.accesstomedicineindex.org/
 – Continua Health Alliance: http://www.continuaalliance.org/index.html 
 – Indian Ministry of Statistics and Programme Implementation (MOSPI): http://mospi.nic.in/Mospi_New/upload/statewise_
sdp1999_2000_9sep10.pdf
 – Indian National Family Health Survey (NFHS): http://www.nfhsindia.org/pdf/Andhra%20Pradesh.pdf
 – PMNCH. Strategic Framework 2012 to 2015. Geneva, 2011.
 – PMNCH. Women’s & Children’s Health: Needs and Challenges. Geneva, 2011: http://portal.pmnch.org/downloads/Needs-and-
Challenges.pdf
 – Dennis S and Mutunga C. Funding Common Ground: Cost Estimates For International Reproductive Health. Washington 
DC, Population Action International, 2010: http://populationaction.org/reports/funding-common-ground-cost-estimates-for-
international-reproductive-health/
 – You D, Jones G and Wardlaw T. Levels & Trends in Child Mortality Report 2011. New York, United Nations Inter-agency 
Group for Child Mortality Estimation, 2011: http://www.childinfo.org/files/Child_Mortality_Report_2011.pdf
 – United Nations Population Division: http://www.un.org/esa/population/
 – United Nations General Assembly Resolution A/RES/60/215. Towards Global Partnerships. New York, 2005: http://www.un.
org/Depts/dhl/resguide/r60.htm
 – United Nations. Guidelines on Cooperation between the United Nations and the Private Sector. New York, 2009: 
http://business.un.org/en/assets/ccccd2de-8860-43f4-bf1d-bd88cccde9e7.pdf
 – The World Bank. Country at a Glance Table: http://econ.worldbank.org/WBSITE/EXTERNAL/DATASTATISTICS/0,,contentMDK:204859
16~pagePK:64133150~piPK:64133175~theSitePK:239419~isCURL:Y,00.html
 – World Health Organization. Global Health Expenditure Database. Geneva, 2012: http://apps.who.int/nha/database/
ChoiceDataExplorerRegime.aspx
Relevant principles
 – Human Rights Council. Guiding Principles on Business and Human Rights. New York, 2011: http://www.ohchr.org/documents/
issues/business/A.HRC.17.31.pdf 
 – International Labor Organization, Recommendation concerning HIV and AIDS and the World of Work, 2010 (No.200). 
Geneva, 2010: http://www.ilo.org/wcmsp5/groups/public/---ed_protect/---protrav/---ilo_aids/documents/normativeinstrument/
wcms_142706.pdf
 – UN Global Compact, Save the Children, UNICEF. Children’s Rights and Business Principles. New York, 2012: 
http://www.unglobalcompact.org/docs/issues_doc/human_rights/CRBP/Childrens_Rights_and_Business_Principles.pdf 
 – UN Global Compact, UN Women. Women’s Empowerment Principles. New York, 2011: http://www.unglobalcompact.org/
docs/issues_doc/human_rights/Resources/WEP_EMB_Booklet.pdf 
37
Private Enterprise for Public Health. Opportunities for Business to Improve Women’s and Children’s Health.
Endnotes
1. UNICEF, WHO, The World Bank, UN DESA/Population Division. Levels & Trends in Child Mortality Report 2011 Estimates 
Developed by the UN Inter-agency Group for Child Mortality Estimation. New York, UNICEF, 2011: http://www.childinfo.org/
files/Child_Mortality_Report_2011.pdf
2. WHO, UNICEF, UNFPA, and The World Bank. Trends in Maternal Mortality: 1990 to 2010. Geneva, WHO, 2012: 
http://www.unfpa.org/webdav/site/global/shared/documents/publications/2012/Trends_in_maternal_mortality_A4-1.pdf
3. Women Deliver. Focus on 5: Women’s Health and the MDGs. New York, 2009: http://www.womendeliver.org/assets/Focus-on-5.pdf
4. United Nations Secretary-General. Global Strategy for Women’s and Children’s Health. New York, United Nations, 2010: 
http://www.who.int/pmnch/topics/maternal/201009_globalstrategy_wch/en/index.html
5. World Health Organization and UNICEF. Countdown to 2015 decade report (2000–2010): taking stock of maternal, newborn 
and child survival. Geneva, 2010: http://www.countdown2015mnch.org/
6. United Nations Population Division: http://www.un.org/esa/population/
7. World Health Organization. National Health Accounts: www.who.int/nha/ and see www.countdown2015mnch.org for report 
and full list of countries (chart excludes DPR Korea). 
8. World Health Organization and UNICEF. “Countdown to 2015 decade report (2000–2010): taking stock of maternal, newborn 
and child survival”. World Health Organization, Geneva, 2010: http://www.countdown2015mnch.org/
9. World Health Organization. National Health Accounts: www.who.int/nha/ 
10. Estimates based on data from Countdown to 2015, Census of India 2011, Indian Ministry of Statistics and Programme 
Implementation (MOSPI), Institute of Health Systems Hyderabad, Rockefeller Foundation, Third Indian National Family 
Health Survey (NFHS), United Nation Population Division, World Health Organization Global Health Expenditure 
Database, and World Bank; Assumption: Number of children under 5 are distributed equally across ages 0-5.
11. Porter M and Kramer M. Creating Shared Value: How to Fix Capitalism and Unleash a New Wave of Growth. Harvard 
Business Review, January/February 2011: http://www.fsg.org/tabid/191/ArticleId/241/Default.aspx?srpush=true
12. Barros AJD et al. Brazil: Are Health and Nutrition Programs Reaching the Neediest? Washington DC, The World Bank, 2005.
13. Paim J. The Brazilian health system: history, advances, and challenges. Lancet, vol. 377, no.9779, 21 May 2011, pp1778-1797.
14. Kania J and Kramer M. Collective Impact. Stanford Social Innovation Review, winter 2011.
15. Beira Agricultural Growth Corridor, 2010: http://www.beiracorridor.com/
38
Annex - Women’s and children’s health: 
needs and challenges
Mdg 5: MaterNal Mortality ratio still uNaccePtably high iN MaNy couNtries
Mdg 4: child Mortality rates - Need to accelerate Progress iN africa aNd asia
MaiN causes of death
Causes of deaths in children under 5 years 
(7.6 million deaths every year/ around 21,000 preventable deaths every day) 
Causes of maternal deaths
(287,000 deaths every year/around 1000 preventable deaths every day)
Adapted from: Countdown to 2015, Building a Future for Women and Children, The 2012 Report (2012) and Trends in maternal mortality: 1990 to 2010. WHO, UNICEF, UNFPA 
and The World Bank estimates (2012).
Source: Trends in maternal mortality: 1990 to 2010. WHO, UNICEF, UNFPA and The World Bank estimates (2012).
<20
20–99
100–299
300–549
550–999
≥1000
Population <100 000  
not included in assessment
Not applicable
Source: Levels & Trends in Child Mortality, Report 2010. WHO / UNICEF / UNPD / World Bank (2010). 
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